Shariq Ali

Shariq Ali

Auto-generated profile, based on publicly available information

Shariq Ali

The University of Texas Southwestern Medical Center

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SASanaalarab Al-Enazy
Sanaalarab Al-Enazy
SAShariq Ali
Shariq Ali
NANorah Albekairi
Norah Albekairi
MEMarwa El-Tawil
Marwa El-Tawil
ERErik Rytting
Erik Rytting

14 December 2015 in Therapeutic Delivery
Verified
Journal Article
Closed access
NANorah A Albekairi
Norah A Albekairi
SASanaalarab Al-Enazy
Sanaalarab Al-Enazy
SAShariq Ali
Shariq Ali
ERErik Rytting
Erik Rytting
Background: Fetal arrhythmias can lead to fetal congestive heart failure and hydrops fetalis. Digoxin (the first-line treatment) has low transplacental permeability and high risk of maternal side effects. Biodegradable digoxin-loaded PEGylated poly(lactic-co-glycolic acid) nanoparticles may increase digoxin transport across BeWo b30 cell monolayers (an in vitro model of trophoblast in human placenta) by reducing the drug's interaction with P-gp. Results/methodology: The nanoparticles showed high encapsulation efficiency and sustained release over 48 h. Transport studies revealed significantly increased permeability across BeWo cell layers of digoxin-loaded nanoparticles when compared with free digoxin. P-gp inhibition also increased the permeability of digoxin, but not digoxin-loaded nanoparticles. Conclusion: This represents a novel treatment strategy for fetal cardiovascular disease which may improve maternal and fetal outcomes.

24 January 2018 in Separations
Verified
Journal Article
Open access
PDF file
MSMansi Shah
Mansi Shah
LBLuke Bourner
Luke Bourner
SAShariq Ali
Shariq Ali
SASanaalarab Al-Enazy
Sanaalarab Al-Enazy
MYMenatallah M. Youssef
Menatallah M. Youssef
ERErik Rytting
Erik Rytting
Assessment of drug transport across the placenta is important in understanding the effect of drugs on placental and fetal health. These phenomena can be studied in both in vitro cell lines and ex vivo placental perfusions. We have successfully developed a sensitive yet simple high performance liquid chromatography (HPLC) method coupled with fluorescence detection to determine the concentration of doxorubicin (DXR) in cell culture media for transport studies in human trophoblast cells (BeWo, b30 clone) and in fetal media for placental perfusion experiments. The method was developed based on a protein precipitation technique and was validated in both media types for linearity, intra-day, and inter-day precision and accuracy. The relationship of peak area to concentration was linear with R2 values of 0.99 or greater obtained over the concentration range of 1.5 to 15,000 ng/mL. Despite the high concentrations of albumin in fetal perfusion media (30 mg/mL), the lower limits of detection and quantification for DXR were found to be 1.5 and 5 ng/mL, respectively. This analytical method may be used to study the transport of DXR across BeWo cells and human placenta during placental perfusion studies.


26 February 2018 in Journal of Liquid Chromatography & Related Technologies
Verified
Journal Article
Open access
SAShariq Ali
Shariq Ali
NANoorah A. Albekairi
Noorah A. Albekairi
XWXiao-Ming Wang
Xiao-Ming Wang
SPSvetlana Patrikeeva
Svetlana Patrikeeva
TNTatiana N. Nanovskaya
Tatiana N. Nanovskaya
ERErik Rytting
Erik Rytting
Ex vivo placental perfusion experiments are important in understanding the quantity and mechanisms of xenobiotic transport to the fetus during pregnancy. Our study demonstrates that paclitaxel and antipyrine concentrations in placental perfusion medium containing physiological concentrations of human serum albumin during pregnancy (30 mg/mL) can be quantified by RP-HPLC and UV detection. A liquid-liquid extraction method was developed for the quantification of paclitaxel and celecoxib (internal standard) from perfusion medium. Antipyrine, which is a necessary marker in placental perfusions for determining the validity of experiments and calculating the clearance index of xenobiotics, was also analyzed by HPLC and UV detection. Antipyrine concentrations were determined by HPLC after precipitating the perfusion medium in acetonitrile and separating the precipitated proteins by centrifugation. Concentrations were fitted to linear regressions with R2 values approaching 1. Lower limits of detection for paclitaxel and antipyrine were 100 ng/mL and 200 ng/mL, respectively. Both methods demonstrated high intra-day and inter-day precision and trueness. Additionally, the use of these methods was demonstrated in a placental perfusion experiment using Taxol® (paclitaxel dissolved in Cremophor-EL). The fetal transfer rate of Taxol was 6.6% after 1 hour.

25 March 2016
Verified
Book Chapter
Closed access
PDF file
IKIrina Kalashnikova
Irina Kalashnikova
NANorah Albekairi
Norah Albekairi
SAShariq Ali
Shariq Ali
SESanaalarab Al Enazy
Sanaalarab Al Enazy
ERErik Rytting
Erik Rytting